Surmodics, Inc. (SRDX)

NASDAQ: SRDX · Real-Time Price · USD

29.14

+0.09 (0.31%)

Jun 18, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
Medical Device	97.51M	Log In	Log In	Log In	Log In	Upgrade
Medical Device Growth	-7.82%	Log In	Log In	Log In	Log In	Upgrade
In Vitro Diagnostics	28.57M	Log In	Log In	Log In	Log In	Upgrade
In Vitro Diagnostics Growth	6.60%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
United States	104.64M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-3.75%	Log In	Log In	Log In	Log In	Upgrade
Foreign	21.43M	Log In	Log In	Log In	Log In	Upgrade
Foreign Growth	-10.19%	Log In	Log In	Log In	Log In	Upgrade